Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling

R. Cohen; D.J. Vugts; G.W.M. Visser; M. Stigter-van Walsum; M. Bolijn; M. Spiga; P. Lazzari; S. Shankar; M. Sani; M. Zanda; G.A.M.S. van Dongen

doi:https://doi.org/10.1158/0008-5472.CAN-14-1141

Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling

R. Cohen, D.J. Vugts, G.W.M. Visser, M. Stigter-van Walsum, M. Bolijn, M. Spiga, P. Lazzari, S. Shankar, M. Sani, M. Zanda, G.A.M.S. van Dongen

Research output: Contribution to journal › Article › Academic › peer-review

66 Citations (Scopus)

Original language	English
Pages (from-to)	5700-5710
Journal	Cancer research
Volume	74
Issue number	20
DOIs	https://doi.org/10.1158/0008-5472.CAN-14-1141
Publication status	Published - 2014

Access to Document

https://doi.org/10.1158/0008-5472.CAN-14-1141

Cite this

@article{d822f0210a514c6195088ed270e71e76,

title = "Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling",

author = "R. Cohen and D.J. Vugts and G.W.M. Visser and {Stigter-van Walsum}, M. and M. Bolijn and M. Spiga and P. Lazzari and S. Shankar and M. Sani and M. Zanda and {van Dongen}, G.A.M.S.",

year = "2014",

doi = "https://doi.org/10.1158/0008-5472.CAN-14-1141",

language = "English",

volume = "74",

pages = "5700--5710",

journal = "Cancer research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "20",

}

TY - JOUR

T1 - Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling

AU - Cohen, R.

AU - Vugts, D.J.

AU - Visser, G.W.M.

AU - Stigter-van Walsum, M.

AU - Bolijn, M.

AU - Spiga, M.

AU - Lazzari, P.

AU - Shankar, S.

AU - Sani, M.

AU - Zanda, M.

AU - van Dongen, G.A.M.S.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1158/0008-5472.CAN-14-1141

DO - https://doi.org/10.1158/0008-5472.CAN-14-1141

M3 - Article

C2 - 25145670

SN - 0008-5472

VL - 74

SP - 5700

EP - 5710

JO - Cancer research

JF - Cancer research

IS - 20

ER -